Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Vivani Medical Inc VANI

Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight... see more

Recent & Breaking News (NDAQ:VANI)

Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development

Business Wire September 18, 2018

Second Sight Appoints Pat Ryan Chief Operating Officer

Business Wire September 4, 2018

Second Sight to Present at Investor Conferences in September

Business Wire August 22, 2018

Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors

Business Wire August 16, 2018

Second Sight Reports Second Quarter 2018 Financial Results

Business Wire August 7, 2018

Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call

Business Wire July 31, 2018

Analysis: Positioning to Benefit within Second Sight Medical Products, ICF International, Morningstar, Spark Therapeutics, Natera, and Kadmon — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire June 21, 2018

Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference

Business Wire May 14, 2018

Second Sight Reports First Quarter 2018 Financial Results

Business Wire May 10, 2018

Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors

Business Wire May 7, 2018

Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call

Business Wire May 3, 2018

Second Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the Company

Business Wire April 9, 2018

Second Sight Appoints John T. Blake Chief Financial Officer

Business Wire March 22, 2018

Research Report Identifies Anthera Pharmaceuticals, Hancock Holding, MKS Instruments, Second Sight Medical Products, Eclipse Resources, and Aircastle with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

GlobeNewswire March 19, 2018

Second Sight Appoints Gregg Williams as Chairman of the Board of Directors

Business Wire March 16, 2018

Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium

Business Wire March 8, 2018

Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results

Business Wire March 7, 2018

Second Sight Medical Products, Inc. to Host Earnings Call

Accesswire March 7, 2018

Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System

Business Wire March 6, 2018

Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018

Business Wire March 5, 2018